There are many different treatment options for various types of scars so the cost would depend on the type of scar, location, how large the scar is, and what treatments would be necessary. Keloidal or hypertrophic (raised) scars are treated with intralesional injections with steroids or chemotherapy agents such as 5-FU (5-fluorouracil) or bleomycin, and also with certain lasers. Other scars may benefit from resurfacing lasers such as CO2, Erbium, Fractionated CO2, or Fraxel treatments. The overall price can range from $75 for one steroid injection to several thousand dollars if several lasers are used and if multiple treatments with multiple devices are required for large exstensive areas. It is necessary to have a consultation with a knowledgeable board-certified dermatologist who specializes in treatment of scars.
The adverse effects of corticosteroids in pediatric patients are similar to those in adults (see ADVERSE REACTIONS ). Like adults, pediatric patients should be carefully observed with frequent measurements of blood pressure, weight, height, intraocular pressure, and clinical evaluation for the presence of infection, psychosocial disturbances, thromboembolism , peptic ulcers, cataracts, and osteoporosis. Pediatric patients who are treated with corticosteroids by any route, including systemically administered corticosteroids, may experience a decrease in their growth velocity. This negative impact of corticosteroids on growth has been observed at low systemic doses and in the absence of laboratory evidence of HPA axis suppression (ie, cosyntropin stimulation and basal cortisol plasma levels). Growth velocity may therefore be a more sensitive indicator of systemic corticosteroid exposure in pediatric patients than some commonly used tests of HPA axis function. The linear growth of pediatric patients treated with corticosteroids should be monitored, and the potential growth effects of prolonged treatment should be weighed against clinical benefits obtained and the availability of treatment alternatives. In order to minimize the potential growth effects of corticosteroids, pediatric patients should be titrated to the lowest effective dose.